Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
Open Access
- 20 October 2015
- journal article
- review article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2015, 1-8
Abstract
Since the identification of PLA2R (M-type phospholipase A2 receptor) as the first human antigenic target in primary membranous nephropathy (MN), perpetual progress has been made in understanding the pathogenesis of this disease. Accumulating clinical data support a pathogenic role for the anti-PLA2R antibodies (PLA2R ABs), but confirmation in an animal model is still lacking. However, PLA2R ABs were related to disease activity and outcome, as well as to response therapy. Accordingly, PLA2R ABs assay seems to be promising tool not only to diagnose MN but also to predict the course of the disease and could open the way to personalize therapy. Nevertheless, validation of a universal assay with high precision and definition of cut-off levels, followed by larger studies with a prolonged follow-up period, are needed to confirm these prospects.Keywords
This publication has 60 references indexed in Scilit:
- Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous NephropathyPLOS ONE, 2013
- IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 ReceptorInternational Journal of Rheumatology, 2012
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2011
- An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritisNephrology Dialysis Transplantation, 2011
- The Natural History of the Non-Nephrotic Membranous Nephropathy PatientClinical Journal of the American Society of Nephrology, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Clinicopathologic correlations of renal pathology in SpainKidney International, 2004
- The mannose receptor familyBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- Predominance of Type-2 Immune Response in Idiopathic Membranous NephropathyNephron, 2002